Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro
about
Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?HIV and intestinal parasite co-infections among a Chinese population: an immunological profileAutoimmune mechanisms of depletion of CD4 cells in HIV infection.Type 1/Type 2 immunity in infectious diseases.Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies.Immune-based therapies: a review of clinical endpoints used in trials of selected immunologic agents.Pathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective.Low CD1c + myeloid dendritic cell counts correlated with a high risk of rapid disease progression during early HIV-1 infection.Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses.Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigensInvestigational agents for treatment of AIDS-related Kaposi's sarcoma.Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.Dendritic cell dysregulation during HIV-1 infection.IL-12 reverses established tolerance mediated by TCRalphabeta+ but not by TCRgammadelta+ suppressor T cells.Expression of macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response.Immune-based therapies for treatment of HIV infection.Does exposure to UV radiation induce a shift to a Th-2-like immune reaction?Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder.Signal transduction by interleukin-12 and interleukin-2. A comparison and contrast.Proinflammatory and immunoregulatory functions of interleukin-12.HIV-1 Nef inhibits lipopolysaccharide-induced IL-12p40 expression by inhibiting JNK-activated NFkappaB in human monocytic cells.Protective immunity to Listeria monocytogenes elicited by immunization with heat-killed Listeria and IL-12. Potential mechanism of IL-12 adjuvanticity.The effects of CD40 ligation on peripheral blood mononuclear cell interleukin-12 and interleukin-15 production and on monocyte CD14 surface antigen expression in human immunodeficiency virus-positive patients.Interleukin-12 and infectious diseases: a potential novel therapy.Cytokines and chemokines in HIV infection: implications for therapy.Priming of T-cell responses in mice by porins of Salmonella typhimurium.Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response.IL-23 and IL-12p70 production by monocytes and dendritic cells in primary HIV-1 infection
P2860
Q26865388-6FCF8CF2-8A30-470A-BC2B-302CEE5C1368Q27499292-E1B62699-0260-4F42-B79C-D0FF9385BACCQ34062232-6E61184F-8137-4671-8629-770024E1E336Q34105379-B6D2CEC5-2316-4B8D-A86E-1A7FB4A31FAAQ34255648-DFC0FE42-979E-4BA9-9B79-2F89B91AA2BCQ34511936-F9BB8379-90F3-438B-B110-D7AD4092B915Q34650866-3C3F88F4-BB8A-4233-9B94-0CE2B73DD127Q35749350-D7CDD09B-4E2D-40FE-B9FB-FC95C206E9B5Q35957193-40593EA3-0B28-4670-B17A-2E956A5094F0Q36011366-B03E6C5C-5119-4F94-8316-A98C5AB3F56AQ36376548-4C217842-95C6-4EEA-8B9D-9DBB0E5735E3Q36603484-02D8285E-2620-4BF8-A6EA-C376C6EC2DA5Q36764020-8F31B015-8F53-4652-9CD0-EAFA7E5534D5Q37039032-869CE700-FE56-4A47-9EDC-77EB92317D04Q38114911-8F9DD6B0-84A5-4911-9382-36A45C2B4D64Q38496023-D30EAC67-F914-47F2-97A8-14FAA9F09B42Q39534952-6E45C898-AFAB-4EE4-9754-E38DEE6582DCQ40959127-894C146B-867F-4B3E-9A0F-62420EC6B948Q41076992-9EF42BE3-9AA7-4AE0-9EF8-388528666C12Q41169392-4457BCE2-DB1E-4514-BE12-84203399074EQ41261282-AC948489-E7B1-45F5-A668-7F4EEB50B3DAQ41722212-3ABDEADC-7AEF-4D87-B2AE-436C0AA376B5Q42084744-9A2E714A-6263-4879-BB17-5B0D22362B42Q43721168-F2247C78-0465-4347-9D97-FCC26DAF7110Q45750402-EADA3418-7101-43B1-A801-55F19C19DAB0Q47619814-46527319-5EFB-4845-B6AC-AF4760060B1CQ47912506-1EDF2C0F-03FF-47D9-9D49-BCF5F3FABF82Q50129647-13766660-AA31-4A26-8B87-3DE0220D6618Q50976561-C5333E83-2FFD-4600-8595-766A5D551B67Q54008411-94EB72CD-B9E1-45E5-B363-E96661DE12C3Q57583339-35499C3A-03F6-46B9-A56B-C73424BEA4C4
P2860
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro
description
article publié dans la revue scientifique Science
@fr
im Dezember 1993 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Science
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1993
@uk
name
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro
@en
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro
@nl
type
label
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro
@en
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro
@nl
prefLabel
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro
@en
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro
@nl
P2093
P356
P1433
P1476
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro
@en
P2093
C W Hendrix
G M Shearer
J A Berzofsky
P304
P356
10.1126/SCIENCE.7903123
P407
P577
1993-12-01T00:00:00Z